Sanofi Settles With Teva, Others Over Generic Eloxatin
Sanofi-Aventis SA has settled patent litigation against three drugmakers — Teva Pharmaceuticals Inc., Fresenius Kabi Pharmaceuticals Holding Inc. and Sandoz Inc. — over their plans to sell generic versions of cancer...To view the full article, register now.
Already a subscriber? Click here to view full article